BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Staging
42 results:

  • 1. Perioperative Durvalumab for Resectable Non-Small-Cell lung cancer.
    Heymach JV; Harpole D; Mitsudomi T; Taube JM; Galffy G; Hochmair M; Winder T; Zukov R; Garbaos G; Gao S; Kuroda H; Ostoros G; Tran TV; You J; Lee KY; Antonuzzo L; Papai-Szekely Z; Akamatsu H; Biswas B; Spira A; Crawford J; Le HT; Aperghis M; Doherty GJ; Mann H; Fouad TM; Reck M;
    N Engl J Med; 2023 Nov; 389(18):1672-1684. PubMed ID: 37870974
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
    He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
    Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis.
    Liu J; Shen B; Yang Y; Guo J; Ren W; Zhou Q; Mao J; Ye W; Wu D
    Acta Oncol; 2023 Mar; 62(3):305-314. PubMed ID: 37010509
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
    [No Abstract]    [Full Text] [Related]  

  • 5. Computed DWI MRI Results in Superior Capability for N-Stage Assessment of Non-Small Cell lung cancer Than That of Actual DWI, STIR Imaging, and FDG-PET/CT.
    Ohno Y; Yui M; Takenaka D; Yoshikawa T; Koyama H; Kassai Y; Yamamoto K; Oshima Y; Hamabuchi N; Hanamatsu S; Obama Y; Ueda T; Ikeda H; Hattori H; Murayama K; Toyama H
    J Magn Reson Imaging; 2023 Jan; 57(1):259-272. PubMed ID: 35753082
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. BSREM for Brain Metastasis Detection with 18F-FDG-PET/CT in lung cancer Patients.
    Liberini V; Pizzuto DA; Messerli M; Orita E; Grünig H; Maurer A; Mader C; Husmann L; Deandreis D; Kotasidis F; Trinckauf J; Curioni A; Opitz I; Winklhofer S; Huellner MW
    J Digit Imaging; 2022 Jun; 35(3):581-593. PubMed ID: 35212859
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
    Shi R; Bao X; Unger K; Sun J; Lu S; Manapov F; Wang X; Belka C; Li M
    Theranostics; 2021; 11(10):5061-5076. PubMed ID: 33754044
    [No Abstract]    [Full Text] [Related]  

  • 8. Prognostic impact of maximum standardized uptake value on
    Qiu X; Liang H; Zhong W; Zhao J; Chen M; Zhu Z; Xu Y; Wang M
    Thorac Cancer; 2021 Mar; 12(6):845-853. PubMed ID: 33512768
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gender and lung cancer-SEER-based analysis.
    Tolwin Y; Gillis R; Peled N
    Ann Epidemiol; 2020 Jun; 46():14-19. PubMed ID: 32532368
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom.
    Cea Soriano L; Zong J; García Rodríguez LA
    BMC Cancer; 2019 Jan; 19(1):91. PubMed ID: 30665371
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key.
    Kaur H; Sehgal IS; Bal A; Gupta N; Behera D; Das A; Singh N
    Indian J Cancer; 2017; 54(1):285-290. PubMed ID: 29199707
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Clinical Characteristics of 118 Cases of Chronic Obstructive Pulmonary Disease Complicated with Primary Bronchopulmonary Carcinoma].
    Zhao S; Nie X; Zhang L; Zhang W; Xiao H
    Zhongguo Fei Ai Za Zhi; 2017 Aug; 20(8):538-542. PubMed ID: 28855034
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Consequences of Referral Time and Volume Doubling Time in Inoperable Patients With Early Stage lung cancer.
    Frelinghuysen M; Fest J; Van der Voort Van Zyp NC; Van der Holt B; Hoogeman M; Nuyttens J
    Clin Lung Cancer; 2017 Nov; 18(6):e403-e409. PubMed ID: 28571689
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cost-effectiveness of mediastinal lymph node staging in non-small cell lung cancer.
    Czarnecka-Kujawa K; Rochau U; Siebert U; Atenafu E; Darling G; Waddell TK; Pierre A; De Perrot M; Cypel M; Keshavjee S; Yasufuku K
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1567-1578. PubMed ID: 28283236
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
    Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
    World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.
    Schmidt-Hansen M; Baldwin DR; Hasler E; Zamora J; Abraira V; Roqué I Figuls M
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009519. PubMed ID: 25393718
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.
    Pass HI; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Rusch VW;
    J Thorac Oncol; 2014 Jun; 9(6):856-64. PubMed ID: 24807157
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Expression and significance of MIF and CD147 in non-small cell lung cancer].
    Liu Q; Yang H; Zhang SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):85-90. PubMed ID: 20369477
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.